Overview

Bioavailability Study of Famotidine Tablets 40 mg Under Fasting Conditions

Status:
Completed
Trial end date:
1998-10-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to compare the single-dose relative bioavailability of Reddy Cheminor and Merck &Co, pepcid 40 mg famotidine tablets under fasting conditions.
Phase:
Phase 1
Details
Lead Sponsor:
Dr. Reddy's Laboratories Limited
Treatments:
Famotidine